{"id":"https://openalex.org/W4309657291","doi":"https://doi.org/10.1093/cid/ciac671","title":"Long-Acting Formulations for the Prevention and Treatment of Human Immunodeficiency Virus (HIV)-1 Infection: Strategic Leveraging and Integration of Multidisciplinary Knowledge to Advance Public Health","display_name":"Long-Acting Formulations for the Prevention and Treatment of Human Immunodeficiency Virus (HIV)-1 Infection: Strategic Leveraging and Integration of Multidisciplinary Knowledge to Advance Public Health","publication_year":2022,"publication_date":"2022-08-24","ids":{"openalex":"https://openalex.org/W4309657291","doi":"https://doi.org/10.1093/cid/ciac671","pmid":"https://pubmed.ncbi.nlm.nih.gov/36410378"},"language":"en","primary_location":{"id":"doi:10.1093/cid/ciac671","doi":"https://doi.org/10.1093/cid/ciac671","is_oa":true,"landing_page_url":"https://doi.org/10.1093/cid/ciac671","pdf_url":"https://academic.oup.com/cid/article-pdf/75/Supplement_4/S498/47170361/ciac671.pdf","source":{"id":"https://openalex.org/S72350973","display_name":"Clinical Infectious Diseases","issn_l":"1058-4838","issn":["1058-4838","1537-6591"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Infectious Diseases","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://academic.oup.com/cid/article-pdf/75/Supplement_4/S498/47170361/ciac671.pdf","any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5000400023","display_name":"Vikram Arya","orcid":"https://orcid.org/0000-0003-3575-0568","observed_orcids":["https://orcid.org/0000-0003-3575-0568"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Vikram Arya","raw_affiliation_strings":["Division of Infectious Disease Pharmacology, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration , Silver Spring, Maryland , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infectious Disease Pharmacology, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, Food and Drug Administration , Silver Spring, Maryland , USA","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031082330","display_name":"Aimee C. Hodowanec","orcid":"https://orcid.org/0009-0006-0749-720X","observed_orcids":["https://orcid.org/0009-0006-0749-720X"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aimee C Hodowanec","raw_affiliation_strings":["Division of Antivirals, Office of Infectious Diseases, Center for Drug Evaluation and Research, Food and Drug Administration , Silver Spring, Maryland , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Antivirals, Office of Infectious Diseases, Center for Drug Evaluation and Research, Food and Drug Administration , Silver Spring, Maryland , USA","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053137835","display_name":"Stephanie B. Troy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephanie B Troy","raw_affiliation_strings":["Division of Antivirals, Office of Infectious Diseases, Center for Drug Evaluation and Research, Food and Drug Administration , Silver Spring, Maryland , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Antivirals, Office of Infectious Diseases, Center for Drug Evaluation and Research, Food and Drug Administration , Silver Spring, Maryland , USA","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5028775745","display_name":"Kimberly A. Struble","orcid":"https://orcid.org/0000-0001-9618-0875","observed_orcids":["https://orcid.org/0000-0001-9618-0875"]},"institutions":[{"id":"https://openalex.org/I1320320070","display_name":"United States Food and Drug Administration","ror":"https://ror.org/034xvzb47","country_code":"US","type":"government","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070"]},{"id":"https://openalex.org/I1333606569","display_name":"Center for Drug Evaluation and Research","ror":"https://ror.org/00yf3tm42","country_code":"US","type":"facility","lineage":["https://openalex.org/I1299022934","https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Kimberly A Struble","raw_affiliation_strings":["Division of Antivirals, Office of Infectious Diseases, Center for Drug Evaluation and Research, Food and Drug Administration , Silver Spring, Maryland , USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Antivirals, Office of Infectious Diseases, Center for Drug Evaluation and Research, Food and Drug Administration , Silver Spring, Maryland , USA","institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5028775745"],"corresponding_institution_ids":["https://openalex.org/I1320320070","https://openalex.org/I1333606569"],"apc_list":{"value":4320,"currency":"USD","value_usd":4320},"apc_paid":{"value":4320,"currency":"USD","value_usd":4320},"fwci":0.4882,"has_fulltext":true,"cited_by_count":5,"citation_normalized_percentile":{"value":0.6445523,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":93,"max":96},"biblio":{"volume":"75","issue":"Supplement_4","first_page":"S498","last_page":"S501"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9398999810218811,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9398999810218811,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.05559999868273735,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.0024999999441206455,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/long-acting-antiretrovirals","display_name":"long-acting antiretrovirals","score":0.9900000095367432},{"id":"https://openalex.org/keywords/hiv-1-infection","display_name":"HIV-1 infection","score":0.8830000162124634},{"id":"https://openalex.org/keywords/hiv-prevention","display_name":"HIV prevention","score":0.9279999732971191},{"id":"https://openalex.org/keywords/hiv-treatment","display_name":"HIV treatment","score":0.9399999976158142},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.7390000224113464},{"id":"https://openalex.org/keywords/prodrugs","display_name":"prodrugs","score":0.6909999847412109},{"id":"https://openalex.org/keywords/chronic-viral-infection","display_name":"chronic viral infection","score":0.7699999809265137},{"id":"https://openalex.org/keywords/data-gaps","display_name":"data gaps","score":0.41600000858306885}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.810131311416626},{"id":"https://openalex.org/C22467394","wikidata":"https://www.wikidata.org/wiki/Q849359","display_name":"Multidisciplinary approach","level":2,"score":0.7032400369644165},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.6327784657478333},{"id":"https://openalex.org/C153083717","wikidata":"https://www.wikidata.org/wiki/Q6535263","display_name":"Leverage (statistics)","level":2,"score":0.5521291494369507},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.5232499837875366},{"id":"https://openalex.org/C64903051","wikidata":"https://www.wikidata.org/wiki/Q2198549","display_name":"Drug development","level":3,"score":0.5191742181777954},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.3960930407047272},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3041383624076843},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.13854622840881348},{"id":"https://openalex.org/C154945302","wikidata":"https://www.wikidata.org/wiki/Q11660","display_name":"Artificial intelligence","level":1,"score":0.09716930985450745},{"id":"https://openalex.org/C144024400","wikidata":"https://www.wikidata.org/wiki/Q21201","display_name":"Sociology","level":0,"score":0.0},{"id":"https://openalex.org/C36289849","wikidata":"https://www.wikidata.org/wiki/Q34749","display_name":"Social science","level":1,"score":0.0},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0}],"mesh":[{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011634","descriptor_name":"Public Health","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D044966","descriptor_name":"Anti-Retroviral Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1093/cid/ciac671","doi":"https://doi.org/10.1093/cid/ciac671","is_oa":true,"landing_page_url":"https://doi.org/10.1093/cid/ciac671","pdf_url":"https://academic.oup.com/cid/article-pdf/75/Supplement_4/S498/47170361/ciac671.pdf","source":{"id":"https://openalex.org/S72350973","display_name":"Clinical Infectious Diseases","issn_l":"1058-4838","issn":["1058-4838","1537-6591"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Infectious Diseases","raw_type":"journal-article"},{"id":"pmid:36410378","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/36410378","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1093/cid/ciac671","doi":"https://doi.org/10.1093/cid/ciac671","is_oa":true,"landing_page_url":"https://doi.org/10.1093/cid/ciac671","pdf_url":"https://academic.oup.com/cid/article-pdf/75/Supplement_4/S498/47170361/ciac671.pdf","source":{"id":"https://openalex.org/S72350973","display_name":"Clinical Infectious Diseases","issn_l":"1058-4838","issn":["1058-4838","1537-6591"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"public-domain","license_id":"https://openalex.org/licenses/public-domain","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Infectious Diseases","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9922999739646912}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4309657291.pdf","grobid_xml":"https://content.openalex.org/works/W4309657291.grobid-xml"},"referenced_works_count":16,"referenced_works":["https://openalex.org/W618752614","https://openalex.org/W645671618","https://openalex.org/W1552317649","https://openalex.org/W2315025523","https://openalex.org/W2475857717","https://openalex.org/W2729232298","https://openalex.org/W2794862768","https://openalex.org/W2898368813","https://openalex.org/W2899500909","https://openalex.org/W2906252243","https://openalex.org/W2910555254","https://openalex.org/W2943490994","https://openalex.org/W2971709414","https://openalex.org/W3096521116","https://openalex.org/W3161159842","https://openalex.org/W4280580004"],"related_works":["https://openalex.org/W2971709414","https://openalex.org/W2729232298","https://openalex.org/W4405941686","https://openalex.org/W4400659888","https://openalex.org/W4400660321","https://openalex.org/W4384023277","https://openalex.org/W2297148143","https://openalex.org/W4401630547","https://openalex.org/W2081072651","https://openalex.org/W4414265433"],"abstract_inverted_index":{"The":[0,37,74],"landscape":[1],"for":[2,7,85,201,208],"the":[3,25,58,62,66,157,165,192],"development":[4,67,86,92,154],"of":[5,11,31,68,76,87,109,119,126,134,159,167,176,187,197],"therapeutics":[6,198],"prevention":[8,33,203],"and":[9,34,54,70,97,114,139,163,174,195,204],"treatment":[10,35,205],"human":[12],"immunodeficiency":[13],"virus":[14],"(HIV)-1":[15],"infection":[16],"has":[17],"pivoted":[18],"towards":[19],"long-acting":[20],"antiretrovirals":[21],"(LA-ARVs).":[22],"LA-ARVs":[23,177],"have":[24],"potential":[26,41,83,141],"to":[27,39,64,80,143],"transform":[28],"global":[29],"implementation":[30],"HIV-1":[32,202],"strategies.":[36],"ability":[38],"identify":[40],"knowledge":[42,189],"gaps":[43],"early":[44],"in":[45,178],"development,":[46,193],"proactively":[47],"address":[48],"missing":[49],"information":[50,60,135],"or":[51],"data":[52],"gaps,":[53],"strategically":[55],"leverage":[56,144],"all":[57],"available":[59,145],"is":[61,79],"key":[63],"streamline":[65],"safe":[69],"effective":[71],"LA-ARV":[72,152],"therapeutics.":[73],"purpose":[75],"this":[77],"article":[78],"discuss":[81,140,149],"some":[82,150],"considerations":[84],"LA-ARVs.":[88],"Three":[89],"possible":[90],"drug":[91,153],"scenarios":[93],"are":[94],"briefly":[95,130],"discussed":[96],"include":[98],"developing":[99],"(1)":[100],"a":[101,105],"novel":[102,106],"LA-ARV,":[103],"(2)":[104],"LA":[107,117],"formulation":[108],"an":[110,116,120,160],"approved":[111,121],"oral":[112,122,161],"ARV,":[113],"(3)":[115],"pro-drug":[118],"ARV.":[123],"For":[124],"each":[125],"these":[127],"scenarios,":[128],"we":[129,148],"describe":[131],"what":[132],"type(s)":[133],"may":[136],"be":[137],"helpful":[138],"opportunities":[142],"information.":[146],"Additionally,":[147],"unique":[151],"considerations,":[155],"including":[156],"use":[158],"lead-in,":[162],"assessing":[164],"impact":[166],"residual":[168],"ARV":[169],"exposures":[170],"on":[171],"subsequent":[172],"regimens":[173],"evaluation":[175],"specific":[179],"populations.":[180],"We":[181],"strongly":[182],"believe":[183],"that":[184],"efficient":[185],"integration":[186],"multidisciplinary":[188],"can":[190],"advance":[191],"availability,":[194],"accessibility":[196],"not":[199],"only":[200],"but":[206],"also":[207],"other":[209],"chronic":[210],"viral":[211],"infections.":[212]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2024,"cited_by_count":2},{"year":2023,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2022-11-29T00:00:00"}
